Not sure how you could interpret that tweet so neg

Not sure how you could interpret that tweet so negative $AMBS short term when the tweet doesn't actually say "short term". He may have meant long term, or possibly just meant stocks to write about on his blog.

Quote:

---

Some of my better ideas right now as written by Jason and not mentioning Ambs is interpreted by me as that Ambs is not one of his short term better idea so to invest in. If I misinterpreted then so bet it but that is how I read it. But I never said he thought Ambs was a bad investment just not one to look at for short term.

---

He just posted this on the 13th.

Quote:

---

"We believe MSPrecise® is a good fit for Amarantus and will serve as a solid foundation upon which to build a successful diagnostics business. As we mentioned in our “15 Biotech Name for 2015” article, Amarantus has been discussing the possibility of spinning out LymPro into a separately traded diagnostic division in 2015. In the article we state that the company would need to package LymPro with another diagnostic product in CNS, and we believe that MSPrecise® certainly fits the criteria. At this point, we would not be surprised to see the spin-out of Amarantus Diagnostics sometime in the next six months, a move we feel could unlock significant value for shareholders. "

---

Link ~ AMBS